Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience powered by Apple
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions powered by Apple

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/

Press Release

Tendance : les Français font confiance aux médicaments, moins aux industriels

déc. 17, 2018
  • Locations
  • France
  • Tendance : les Français font confiance aux médicaments, moins aux industriels

Selon les résultats du huitième observatoire sociétal du médicament*, présentés par le Leem le 13 novembre dernier, 77 % des Français font confiance aux médicaments**. « Un chiffre en voie de stabilisation, après une baisse de huit points entre 2015 et 2017 », souligne l’organisation. Les spécialités thérapeutiques remboursées (84 %), prescrites (83 %) et de marque (79 %) sont jugées plus favorablement que les génériques (69 %), les médicaments non remboursés (66 %) ou ceux vendus sans ordonnance (65 %).

Autre enseignement de ce sondage : la cote des vaccins semble remonter dans l’opinion publique. 52 % des participants considèrent les bénéfices supérieurs aux risques, contre 44 % l’an dernier. La catégorie des 25-34 ans connaît même une progression de 18 points cette année (49 %). Les personnes âgées de 65 ans et plus affichent le degré de confiance le plus élevé en la matière (57 %).

 

Les laboratoires suscitent (toujours) la méfiance
Malgré une hausse de deux points, l’image des laboratoires reste pourtant mitigée aux yeux des Français**. Seuls 49 % des répondants leur font confiance. A titre de comparaison, l’industrie pharmaceutique se situe derrière l’aéronautique (77 %) ou le numérique (58 %), mais devant le nucléaire (37 %), la grande distribution (36 %) et la banque/assurance (34 %).

La plupart des personnes interrogées reconnaissent une légitimité aux industriels dans les domaines de la recherche (88 %), des essais cliniques (80 %), de la sécurité des médicaments (79 %) ou de la participation aux discussions sur les enjeux du système de santé (66 %), mais ils doutent de l’éthique (66 %) et de la transparence du secteur (84 %).

 

(*) Ce sondage a été réalisé par l’Institut Ipsos pour le compte du Leem. 1 000 personnes ont été interrogées via internet entre le 28 août et le 5 septembre 2018, sur un échantillon représentatif de la population nationale, âgé de 18 ans et plus.

(**) Les résultats obtenus à partir d’un sur-échantillon de 250 patients chroniques âgés de 18 ans et plus sont meilleurs. Ces derniers font globalement plus confiance aux médicaments (84 %) et aux laboratoires pharmaceutiques (55 %) que les autres personnes sondées.

Contact Us